HEA

Fed slows hike to 50 basis points in September, recession concerns mount, Reuters polls show

Fed slows hike to 50 basis points in September, recession concerns mount, Reuters polls show

A resident buys food at a local market, in downtown San Francisco, California, US, July 13, 2022. REUTERS/Carlos Barria/File Photo Register now for FREE unlimited access to Reuters.com Register BENGALURU, Aug. 22 (Reuters) – The US Federal Reserve is set to raise interest rates by 50 basis points in September amid expectations that inflation has …

Fed slows hike to 50 basis points in September, recession concerns mount, Reuters polls show Read More »

Musk approaches brain chip startup Synchron over deal amid Neuralink delays

Musk approaches brain chip startup Synchron over deal amid Neuralink delays

Tesla CEO Elon Musk watches as he visits the construction site of Tesla’s gigafactory in Gruenheide, near Berlin, Germany, May 17, 2021. REUTERS/Michele Tantussia Register now for FREE unlimited access to Reuters.com Register Aug 19 (Reuters) – Elon Musk has announced brain chip implant developer Synchron Inc. approached about a potential investment as his own …

Musk approaches brain chip startup Synchron over deal amid Neuralink delays Read More »

Bluebird's $2.8M Gene Therapy Becomes Most Expensive Drug After U.S. Approval

Bluebird’s $2.8M Gene Therapy Becomes Most Expensive Drug After U.S. Approval

Signage is on display outside the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US, Aug. 29, 2020. REUTERS/Andrew Kelly/File Photo Register now for FREE unlimited access to Reuters.com Register Aug 17 (Reuters) – The U.S. Food and Drug Administration on Wednesday approved bluebird bios (BLUE.O) gene therapy for patients with a rare …

Bluebird’s $2.8M Gene Therapy Becomes Most Expensive Drug After U.S. Approval Read More »